Agreed but the term "generally accepted" kind of threw me.
As PIs we do have some advantages and one of them is not following what is generally accepted.
Had a look here last year and was close but went with alternative. Generally interesting tech but at the time looked a little under cooked. Will have another look.
Good luck to everyone here - investing in healthcare can be rewarding and I'm on the side of the little fellah. Getting in before the big boys is possible since they don't like it up em but I'm wary of anything that states to be nailed on. The big boys have access to resources and insight that enable them to be more considered than a this is ramptastic.
I am thinking the way markets work is that if it was "genetally accepted" a share was worth £1+ the normal laws of supply and demand would apply and the share would be £1+.
At the moment it is less then this which makes me think we have hit on a new model of market efficiency and together we can now sit back and wait for our Nobel prize for economics. Get in
RE: Like I said... 180 to 200p then on to 250 to 300p... Then it starts.13 Jan 2021 11:15
Can you post details of how you can tell one group of sells is linked to another group of buys.
I only ask cause I think its sports direct sellers jumping from there to here. My source is I just made it up but yours might be different. There again maybe not.
Noooooooooo Chengdo cannot go. You don't have to be a shareholder to spout bollix on here. Stay as an honoured guest.
I lookedvat liquid biopsy awhile back - not sure if it was Angel but probably at the same time Centurion was banging on about TILS. I remember thinking they seemed unvalidated whilst the Accumstem had some RWE.
If the blessed reverend RK in then I guess we have missed the pre pump.
Good luck Chengdo - don't always agree but your heart in the right place I believe.
RE: 250p to 300p very short term.... 700p plus within this year.12 Jan 2021 18:40
If we know the price is going to be £11 why isn't everyone jumping in on a no trainer.
I'm thinking it might be because it might not be - rumour has it that the price reflects sentiment by balancing supply and demand to reach a consensus price. Crazy.
I feel it is so that when we win the cup we can bang on endlessly how we used to be here when there were nowt here but six blokes, a dog and a tatty burger van and the team stayed on at half time firba cup of tea and a slice of orange
To be honest if it comes off the company will be too big for him. Board will look to get a Professional CEO. If it fails then I'm afraid he is history at that point.
My prediction is the best he can hope for is either head of preclinical or diagnostics. They need a proper CEO and a proper Head of Clinical Development. In terms of DX I suspect the right guy is in the company just waiting for a call.
Monks head - yep the guy in the white coat seems to be a FAPing expert but I cannot work out if CANSEEK is complimentary or competitive to precision. The point video is not particularly informative.
What we know is they had CANSEEK in November and then rapidly moved to secure precision for their radio ligands. Could be covering bases but you would hope that the Avacta guys would want to have get outs if that was the case.
Anyway really good to see another company with a full set of pictures of people in white coats studiously looking at liquids in funny shaped glass containers
RE: It's My Party (and I'll Cry if I want to)...11 Jan 2021 11:18
I have been reliably informed that Indy is now part of SAGE and will be accompanying Boris for the number 10 press briefings. Currently he is in media training and working up a series of PowerPoint slides. I for one will be tuning in